1. Home
  2. FGEN vs LITB Comparison

FGEN vs LITB Comparison

Compare FGEN & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • LITB
  • Stock Information
  • Founded
  • FGEN 1993
  • LITB 2007
  • Country
  • FGEN United States
  • LITB Singapore
  • Employees
  • FGEN N/A
  • LITB N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • LITB Catalog/Specialty Distribution
  • Sector
  • FGEN Health Care
  • LITB Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • LITB Nasdaq
  • Market Cap
  • FGEN 34.5M
  • LITB 32.2M
  • IPO Year
  • FGEN 2014
  • LITB N/A
  • Fundamental
  • Price
  • FGEN $0.50
  • LITB $1.06
  • Analyst Decision
  • FGEN
  • LITB
  • Analyst Count
  • FGEN 0
  • LITB 0
  • Target Price
  • FGEN N/A
  • LITB N/A
  • AVG Volume (30 Days)
  • FGEN 1.1M
  • LITB 14.3K
  • Earning Date
  • FGEN 02-24-2025
  • LITB 03-24-2025
  • Dividend Yield
  • FGEN N/A
  • LITB N/A
  • EPS Growth
  • FGEN N/A
  • LITB N/A
  • EPS
  • FGEN N/A
  • LITB N/A
  • Revenue
  • FGEN $180,015,000.00
  • LITB $333,093,000.00
  • Revenue This Year
  • FGEN $21.91
  • LITB N/A
  • Revenue Next Year
  • FGEN N/A
  • LITB N/A
  • P/E Ratio
  • FGEN N/A
  • LITB N/A
  • Revenue Growth
  • FGEN 16.15
  • LITB N/A
  • 52 Week Low
  • FGEN $0.18
  • LITB $0.91
  • 52 Week High
  • FGEN $2.93
  • LITB $6.30
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 49.50
  • LITB 36.07
  • Support Level
  • FGEN $0.46
  • LITB $0.91
  • Resistance Level
  • FGEN $0.51
  • LITB $1.15
  • Average True Range (ATR)
  • FGEN 0.05
  • LITB 0.14
  • MACD
  • FGEN -0.01
  • LITB 0.00
  • Stochastic Oscillator
  • FGEN 31.25
  • LITB 22.50

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company is engaged in product sales which consisted of online retailing of consumer products. It also provides services which consisted of the provision of logistic services to e-commerce retailers and small businesses. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: